Table 3 The 40 top differentially expressed genes (DEGs) in non-polyp nasal epithelial mucosa from patients with CRSwNP versus mucosal tissue from controls.

From: Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps

RNA

baseMean

log2FoldChange

lfcSE

stat

p-value

padj

PTP4A1

1777.09

0.97

0.14

6.78

1.21 × 10−11

3.41 × 10−07

FOSB

646.71

4.65

0.70

6.64

3.19 × 10−11

3.95 × 10−07

GP2

1981.93

3.42

0.52

6.57

5.03 × 10−11

3.95 × 10−07

AC096642.1

61.77

 − 1.36

0.21

 − 6.55

5.60 × 10−11

3.95 × 10−07

TCEANC2

369.15

 − 0.65

0.10

 − 6.40

1.59 × 10−10

9.00 × 10−07

KLLN

35.86

 − 0.90

0.14

 − 6.35

2.21 × 10−10

1.04 × 10−06

PTCD2

322.19

 − 0.43

0.07

 − 6.18

6.33 × 10−10

2.55 × 10−06

ELF2

1507.39

0.26

0.04

6.16

7.41 × 10−10

2.61 × 10−06

FOS

2302.83

3.48

0.57

6.12

9.14 × 10−10

2.87 × 10−06

THNSL1

196.42

 − 0.83

0.14

 − 6.07

1.27 × 10−09

3.59 × 10−06

SRSF4

2023.33

0.40

0.07

6.05

1.49 × 10−09

3.82 × 10−06

LINC01578

1582.75

0.40

0.07

5.87

4.28 × 10−09

9.69 × 10−06

RPL5P18

12.89

 − 1.36

0.23

 − 5.87

4.46 × 10−09

9.69 × 10−06

PEX12

151.12

 − 0.55

0.09

 − 5.83

5.66 × 10−09

1.12 × 10−05

ZNF708

518.62

0.34

0.06

5.81

6.22 × 10−09

1.12 × 10−05

TRMO

389.92

0.36

0.06

5.80

6.65 × 10−09

1.12 × 10−05

ADAM20P1

71.89

 − 0.90

0.15

 − 5.80

6.75 × 10−09

1.12 × 10−05

AVL9

1876.16

0.23

0.04

5.78

7.48 × 10−09

1.15 × 10−05

BACH1

1744.81

0.42

0.07

5.77

7.76 × 10−09

1.15 × 10−05

FBXO33

464.49

0.47

0.08

5.76

8.66 × 10−09

1.18 × 10−05

AC105285.1

50.92

 − 0.88

0.15

 − 5.75

8.81 × 10−09

1.18 × 10−05

TRMT1L

658.27

 − 0.49

0.09

 − 5.70

1.17 × 10−08

1.50 × 10−05

SECISBP2

2027.42

0.29

0.05

5.67

1.44 × 10−08

1.77 × 10−05

DACT2

133.52

1.20

0.21

5.64

1.66 × 10−08

1.90 × 10−05

USP3

1582.27

0.33

0.06

5.64

1.68 × 10−08

1.90 × 10−05

HNRNPH1

10 575.10

0.30

0.05

5.62

1.93 × 10−08

1.98 × 10−05

ZNF311

80.44

 − 0.83

0.15

 − 5.61

1.97 × 10−08

1.98 × 10−05

KDM3A

2057.25

0.46

0.08

5.61

2.00 × 10−08

1.98 × 10−05

ZNF292

3415.61

0.40

0.07

5.61

2.04 × 10−08

1.98 × 10−05

RINT1

517.18

0.26

0.05

5.60

2.11 × 10−08

1.98 × 10−05

MAP3K21

260.50

0.62

0.11

5.59

2.30 × 10−08

2.10 × 10−05

USP48

2054.50

0.32

0.06

5.55

2.84 × 10−08

2.51 × 10−05

TTC39C

962.55

0.31

0.06

5.54

3.09 × 10−08

2.64 × 10−05

CCDC112

216.29

0.61

0.11

5.50

3.79 × 10−08

3.07 × 10−05

USP37

1073.22

 − 0.30

0.06

 − 5.49

3.93 × 10−08

3.07 × 10−05

RIC8B

498.24

 − 0.34

0.06

 − 5.49

3.98 × 10−08

3.07 × 10−05

MOAP1

463.38

0.44

0.08

5.49

4.03 × 10−08

3.07 × 10−05

MCMDC2

44.72

 − 0.95

0.17

 − 5.47

4.47 × 10−08

3.32 × 10−05

CBR3-AS1

293.55

0.90

0.17

5.46

4.80 × 10−08

3.40 × 10−05

AC007485.2

78.67

 − 0.53

0.10

 − 5.46

4.81 × 10−08

3.40 × 10−05

  1. The mRNA levels (baseMean) of expressed genes and p-values adjusted using the Benjamini–Hochberg method.
  2. BaseMean mean RNA count, lfcSE log2 Fold Change Standard Error, stat Wald statistic Z-score, padj p-value adjusted.